中文产业新闻评分61Chinese source
诺和诺德口服司美格鲁肽14mg国内获批心血管新适应症，两项代谢适应症申报FDA
速递 | 诺和诺德口服司美格鲁肽迎三重突破，14mg剂型国内新增心血管适应症
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.
速递 | 诺和诺德口服司美格鲁肽迎三重突破，14mg剂型国内新增心血管适应症
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.